✦ LIBER ✦

Treatment of pancreatic cancer with anti-death receptor antibody in combination with Gemcitabine

✍ Scribed by Leo C. DeRosier; Donald Buchsbaum; Jeffrey Sellers; Zhi-Qiang Huang; Patsy Oliver; Selwyn Vickers

Book ID: 113676631
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 49 KB
Volume: 201
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2005.06.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined therapy with anti-death recepto

Combined therapy with anti-death receptor-5 antibody and triptolide induces apoptosis in pancreatic cancer cells

✍ Daniel Borja-Cacho; Zwolak Pawel; Yumi Yokoyama; Jacob S. Ankeny; Mara B. Antono 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Combination therapy with Oxaliplatin + G

Combination therapy with Oxaliplatin + Gemcitabine in advanced pancreatic cancer

✍ R. Klapdor; J. Martini-Svendsen; R. Seutter; C. Fenner 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Combination of irinotecan and anti-death

Combination of irinotecan and anti-death receptor 5 antibody inhibits pancreatic cancer in an orthotopic tumor model

✍ L.C. DeRosier; D.J. Buchsbaum; J.C. Sellers; Z.Q. Huang; P.G. Oliver; S.M. Vicke 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Phase I study of the humanised anti-EGFR

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

✍ Graeven, U; Kremer, B; Südhoff, Th; Killing, B; Rojo, F; Weber, D; Tillner, J; ü 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB

Gastrointestinal bleeding during anti-an

Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer

✍ Hitomi Nagayama; Kazufumi Matsumoto; Naoyuki Isoo; Hideki Ohno; Naoyuki Takahash 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 498 KB

Gemcitabine in combination with 5-fluoro

Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer

✍ Helmut Oettle; Hanno Riess 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

Pancreatic cancer is one of the most frequently reported gastrointestinal tumors and has been reported to have a 5-year survival rate of < 5%. It is most commonly diagnosed at an advanced stage and until recently, the most frequently administered treatment for patients with advanced disease has been